Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Recurrent Pleural Malignant Mesothelioma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00006014
What this trial is testing

SU5416 in Treating Patients With Malignant Mesothelioma

Who this might be right for
Malignant Mesothelioma
National Cancer Institute (NCI) 45
Early research (Phase 1)Study completedNCT00020579
What this trial is testing

MS-275 in Treating Patients With Advanced Solid Tumors or Lymphoma

Who this might be right for
Cancer
National Institutes of Health Clinical Center (CC) 75
Testing effectiveness (Phase 2)Study completedNCT00243074
What this trial is testing

S0509 - AZD2171 in Treating Patients With Malignant Pleural Mesothelioma That Cannot Be Removed By Surgery

Who this might be right for
Advanced Malignant MesotheliomaEpithelial MesotheliomaRecurrent Malignant Mesothelioma+1 more
National Cancer Institute (NCI) 54
Testing effectiveness (Phase 2)WithdrawnNCT01105390
What this trial is testing

AMG 102, Pemetrexed Disodium, and Cisplatin in Treating Patients With Malignant Pleural Mesothelioma

Who this might be right for
Advanced Malignant MesotheliomaEpithelial MesotheliomaRecurrent Malignant Mesothelioma+1 more
National Cancer Institute (NCI)
Early research (Phase 1)Study completedNCT00066404
What this trial is testing

Intrapleural BG00001 in Treating Patients With Malignant Pleural Mesothelioma or Malignant Pleural Effusions

Who this might be right for
Cancer
Abramson Cancer Center at Penn Medicine
Early research (Phase 1)Study completedNCT00019825
What this trial is testing

Decitabine in Treating Patients With Unresectable Lung or Esophageal Cancer or Malignant Mesothelioma of the Pleura

Who this might be right for
Esophageal CancerLung CancerMalignant Mesothelioma+1 more
National Cancer Institute (NCI)
Testing effectiveness (Phase 2)Study completedNCT00025207
What this trial is testing

Gefitinib in Treating Patients With Malignant Mesothelioma

Who this might be right for
Advanced Malignant MesotheliomaEpithelial MesotheliomaRecurrent Malignant Mesothelioma+1 more
National Cancer Institute (NCI) 40
Testing effectiveness (Phase 2)Active Not RecruitingNCT03907852
What this trial is testing

Phase 1/2 Trial of Gavo-cel (TC-210) in Patients With Advanced Mesothelin-Expressing Cancer

Who this might be right for
MesotheliomaMesothelioma, MalignantMesothelioma; Pleura+8 more
TCR2 Therapeutics 57
Testing effectiveness (Phase 2)Ended earlyNCT02408016
What this trial is testing

Genetically Modified T Cells in Treating Patients With Stage III-IV Non-small Cell Lung Cancer or Mesothelioma

Who this might be right for
Advanced Pleural Malignant MesotheliomaHLA-A*0201 Positive Cells PresentRecurrent Non-Small Cell Lung Carcinoma+8 more
Fred Hutchinson Cancer Center 11
Testing effectiveness (Phase 2)Study completedNCT00017186
What this trial is testing

Gemcitabine and Epirubicin in Treating Patients With Malignant Mesothelioma

Who this might be right for
Malignant Mesothelioma
Alliance for Clinical Trials in Oncology 69
Testing effectiveness (Phase 2)Study completedNCT02497508
What this trial is testing

Nivolumab in Patients With Recurrent Malignant Mesothelioma

Who this might be right for
Malignant Pleural Mesothelioma
The Netherlands Cancer Institute 33
Testing effectiveness (Phase 2)Active Not RecruitingNCT03074513
What this trial is testing

Atezolizumab and Bevacizumab in Treating Patients With Rare Solid Tumors

Who this might be right for
Appendix AdenocarcinomaHuman Papillomavirus-Related Anal Squamous Cell CarcinomaHuman Papillomavirus-Related Cervical Squamous Cell Carcinoma+18 more
M.D. Anderson Cancer Center 133
Testing effectiveness (Phase 2)UnknownNCT00024271
What this trial is testing

Surgery, Chemotherapy, and Radiation Therapy in Treating Patients With Peritoneal Cancer

Who this might be right for
Malignant Mesothelioma
Herbert Irving Comprehensive Cancer Center
Testing effectiveness (Phase 2)Study completedNCT00039182
What this trial is testing

Erlotinib in Treating Patients With Malignant Mesothelioma of the Lung

Who this might be right for
Advanced Malignant MesotheliomaEpithelial MesotheliomaRecurrent Malignant Mesothelioma+1 more
National Cancer Institute (NCI) 55
Early research (Phase 1)Study completedNCT00398138
What this trial is testing

Vaccine Therapy and GM-CSF in Treating Patients With Acute Myeloid Leukemia, Myelodysplastic Syndromes, Non-Small Cell Lung Cancer, or Mesothelioma

Who this might be right for
LeukemiaLung CancerMalignant Mesothelioma+2 more
Memorial Sloan Kettering Cancer Center 22
Early research (Phase 1)Study completedNCT00030498
What this trial is testing

Erlotinib in Treating Patients With Solid Tumors and Liver or Kidney Dysfunction

Who this might be right for
Adult Anaplastic AstrocytomaAdult Anaplastic EpendymomaAdult Anaplastic Oligodendroglioma+83 more
National Cancer Institute (NCI) 75
Testing effectiveness (Phase 2)Study completedNCT00634205
What this trial is testing

Phase II Study of Valproate and Doxorubicin in Malignant Mesothelioma

Who this might be right for
Malignant Mesothelioma
European Lung Cancer Working Party 45
Not applicableStudy completedNCT00897442
What this trial is testing

Collecting Tumor Samples From Patients With Gynecological Tumors

Who this might be right for
Borderline Ovarian Clear Cell TumorBorderline Ovarian Serous TumorCervical Adenocarcinoma+83 more
Gynecologic Oncology Group 275
Testing effectiveness (Phase 2)Study completedNCT00004033
What this trial is testing

Liposomal-Cisplatin Analogue (L-NDDP) in Treating Patients With Malignant Pleural Mesothelioma

Who this might be right for
Malignant Mesothelioma
NYU Langone Health 30
Large-scale testing (Phase 3)Study completedNCT00821860
What this trial is testing

Video-Assisted Surgery or Talc Pleurodesis in Treating Patients With Malignant Mesothelioma

Who this might be right for
Malignant MesotheliomaMetastatic Cancer
Papworth Hospital NHS Foundation Trust 196
Next Page